阿斯塔桑丁是治疗质母细胞瘤的新型候选药物吗? 一个审查 一个审查
Arian Rezaee1, Mehrsa Radmanesh2, Atena Asghari3
1Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Current medicinal chemistry
|October 16, 2024
概括
阿斯塔克桑丁 (AXT) 在对抗质母细胞瘤 (GBM),一种具有挑战性的脑癌方面表现有前途. 这种天然化合物向活性氧物种并抑制瘤生长,为新的GBM疗法提供了潜力.
科学领域:
- 在瘤学瘤学.
- 自然产品化学 自然产品化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 质母细胞瘤 (GBM) 是一种具有不良预后和高复发率的侵袭性脑瘤.
- 目前的GBM治疗提供了有限的生存益处,无法实现完全治愈.
- 由于瘤复发和治疗耐药性,开发有效的治疗方法具有挑战性.
研究的目的:
- 审查阿斯塔克桑丁 (AXT) 作为治疗质母细胞瘤的新疗剂的潜力.
- 总结目前关于AXT对GBM细胞和动物模型的影响的研究.
- 突出AXT在开发创新的癌症治疗中的作用.
主要方法:
- 对研究阿斯塔山丁对质母细胞瘤的影响的文献综述.
- 对AXT对GBM影响的体外和体内数据的分析.
- 专注于AXT的作用机制,包括准活性氧物种 (ROS).
主要成果:
- 阿斯塔克桑丁 (AXT) 在实验室和动物研究中对质母细胞瘤细胞产生显著影响.
- 已经证明,AXT可以向活性氧物种 (ROS),这是癌症进展的关键因素.
- 有证据表明,在体外和体外条件下,AXT抑制瘤生长.
结论:
- 阿斯塔克桑丁 (AXT) 作为质母细胞瘤 (GBM) 的治疗选择具有相当大的潜力.
- 由于AXT能够向ROS并抑制瘤生长,使其成为新型GBM疗法的有希望的候选者.
- 对AXT的进一步研究可能会导致质母细胞瘤的创新治疗策略.
更多相关视频
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
2.3K
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.4K
相关概念视频
01:15Drugs that Stabilize Microtubules
2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
02:49Cancer Therapies
8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
02:56Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K